Using Fractional Lasers and Tirbanibulin Ointment to Treat Keratinocyte Carcinomas

Status: Recruiting
Location: See location...
Intervention Type: Device, Drug
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY

The investigators seek to evaluate the effectiveness of fractional laser therapy and tirbanibulin ointment to treat squamous and basal cell carcinomas. This will be executed by using both thulium and erbium lasers on previously biopsy-confirmed SCCs and BCCs and applying bulk heating methods. Then, depending on the level of invasiveness, subjects may be instructed to apply the ointment over the course of five nights immediately following the treatment. The intention of this study is to minimize the need for invasive surgical procedures so as to optimize the cosmetic appearance, and provide a treatment option that is beneficial for a wide range of individuals.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
Locations
United States
New York
Bruce Robinson, MD
RECRUITING
New York
Contact Information
Primary
Gillian Nanni, Research Coordinator, BS
info@brucerobinsonmd.com
212-750-7121
Time Frame
Start Date: 2025-05-16
Estimated Completion Date: 2030-06
Participants
Target number of participants: 100
Treatments
Active_comparator: Fractional Laser Only
Treatment of superficial or in situ carcinomas will be with fractional laser only.
Active_comparator: Fractional Laser and Tirbanibulin Ointment
Treatment of nodular or invasive carcinomas will be with fractional laser followed by a course of Klisyri ointment.
Related Therapeutic Areas
Sponsors
Leads: Bruce Robinson, MD

This content was sourced from clinicaltrials.gov